Synaptic biology

While SPP1 absence prevents synaptic loss, it's unclear whether this represents loss of beneficial amyloid clearance or prevention of pathological synapse destruction. This fundamental question affects whether SPP1 should be therapeutically enhanced or inhibited in different disease stages. Gap type: open_question Source paper: Perivascular cells induce microglial phagocytic states and synaptic engulfment via SPP1 in mouse models of Alzheimer's disease. (2023, Nat Neurosci, PMID:36747024)

The abstract describes that IFN-γ-induced moderate nitric oxide release impairs gamma rhythm activity and cognitive functions, but the mechanistic pathway connecting NO to network oscillations is not explained. This gap is crucial since gamma rhythms are fundamental to cognitive processing and are disrupted in multiple neurodegenerative diseases. Gap type: unexplained_observation Source paper: Interferon γ: a master cytokine in microglia-mediated neural network dysfunction and neurodegeneration. (2022, Trends in neurosciences, PMID:36283867)

The authors demonstrate that secreted factors from MAPT IVS10+16 microglia reduce neuronal synaptic density, but the identity of these toxic secretory factors and their mechanisms of synaptic damage are not characterized. This represents a critical gap for developing targeted therapeutic interventions. Gap type: unexplained_observation Source paper: Cell autonomous microglia defects in a stem cell model of frontotemporal dementia tau. (None, None, PMID:40527900)

The study shows Rk1 attenuates Akt upregulation in vitro but increases synaptic proteins in vivo, creating an apparent mechanistic contradiction. The specific downstream signaling events linking PI3K/Akt modulation to enhanced PSD-95 and SYN expression remain unexplained. Gap type: unexplained_observation Source paper: Ginsenoside Rk1 alleviates lipopolysaccharide (LPS)-induced cognitive impairment by modulating synaptic plasticity. (2025, Frontiers in pharmacology, PMID:41646936)

The abstract identifies exerkines as key mediators of exercise-induced neuroplasticity but explicitly notes fundamental gaps in understanding biophysical interactions between muscle activity and brain at cellular levels. This mechanistic gap limits development of targeted exercise interventions and potential therapeutic mimetics. Gap type: open_question Source paper: Exerkines and long-term synaptic potentiation: Mechanisms of exercise-induced neuroplasticity. (2022, Frontiers in neuroendocrinology, PMID:35283168)

The abstract describes PGC-1α roles spanning organelle biogenesis, synaptic development, and multiple glial functions, but the regulatory networks coordinating these diverse processes remain unclear. This knowledge gap limits understanding of how PGC-1α dysfunction contributes to complex neurodegenerative phenotypes. Gap type: unexplained_observation Source paper: Covering the Role of PGC-1α in the Nervous System. (2021, Cells, PMID:35011673)

The study shows that presynaptic P/Q deficits trigger coordinated upregulation of specific postsynaptic ion channel transcripts through a transsynaptic mechanism. However, the molecular identity and signaling pathways mediating this cross-synaptic communication are not characterized. Gap type: unexplained_observation Source paper: Presynaptic P/Q calcium channel deficit promotes postsynaptic excitability remodeling and neurogenesis in developing thalamic circuitry. (2026, Neuron, PMID:41932329)

The abstract mentions that defective NT release generates consequences related to changed synaptic gene and protein activity but provides no details. Identifying these molecular changes is essential for understanding synaptopathy progression. Gap type: unexplained_observation Source paper: Gene therapy targeting synaptopathy linked with Alzheimer's and Parkinson's disease. (2026, Neuroscience, PMID:41730496)